Aterian (NASDAQ: ATER) CFO granted 120,000 restricted shares

Rhea-AI Filing Summary

Aterian, Inc. reported that its Chief Financial Officer, Joshua O. Feldman, received an award of 120,000 shares of common stock on 01/23/2026. These shares are described as restricted stock granted under the company’s 2018 Equity Incentive Plan and are subject to vesting conditions. The filing notes that this award was made outside Aterian’s regular annual equity grant cycle and was approved by the Compensation Committee for retention purposes. Following this grant, Feldman beneficially owns 497,442 shares of Aterian common stock in direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Feldman Joshua O

(Last) (First) (Middle)

350 SPRINGFIELD AVENUE SUITE #200

(Street)

SUMMIT NJ 07901

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aterian, Inc. [ ATER ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/23/2026		A(1)(2)		120,000	A	$0	497,442	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Comprised of shares of restricted common stock granted pursuant to the Issuer's 2018 Equity Incentive Plan that are subject to vesting.

2. The reported award was granted outside of the Company's regular annual equity grant cycle and was approved by the Compensation Committee for retention purposes.

	/s/ Joshua Feldman	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aterian (ATER) disclose in this Form 4?

Aterian disclosed that its Chief Financial Officer, Joshua O. Feldman, received an award of 120,000 shares of common stock on 01/23/2026, reported with transaction code A.

What type of shares did the Aterian CFO receive in this transaction?

The CFO received restricted common stock granted under Aterian’s 2018 Equity Incentive Plan, and these shares are subject to vesting conditions.

Why was the Aterian (ATER) CFO equity award granted outside the regular cycle?

The filing states that the reported award was granted outside Aterian’s regular annual equity grant cycle and was approved by the Compensation Committee for retention purposes.

How many Aterian shares does the CFO own after this grant?

After the reported transaction, Chief Financial Officer Joshua O. Feldman beneficially owns 497,442 shares of Aterian common stock in direct ownership.

Did the Aterian CFO pay a price per share for this restricted stock grant?

The transaction shows a price per share of $0, indicating the restricted stock was granted as an equity award rather than purchased on the market.

What is the role of the reporting person in this Aterian (ATER) Form 4?

The reporting person, Joshua O. Feldman, is identified as an officer of Aterian, serving as the company’s Chief Financial Officer.